stocktitan.net

Battery X Metals partners with bullVestor for premium European marketing initiative. Strategic 190K investment targets enhanced visibility in EU financial markets.

Strategic investment accelerates Sylvan's Asian expansion and R&D capabilities in sustainable biotech. KKR remains majority owner. See growth implications.

First-in-class treatment Vanrafia shows 36% proteinuria reduction in IgAN patients. Major breakthrough for rare kidney disease affecting thousands. Full analysis inside.

RxSight reports Q1 revenue of $37.9M with 36% lens volume growth, but lowers 2025 guidance to $160-175M amid market headwinds. Full analysis inside.

HYTN expands global reach with crucial GMP certifications for US, Israel, and Bermuda markets. Licensed for cannabis and psilocybin pharmaceutical manufacturing. Full analysis inside.

GMV Minerals secures fresh capital to accelerate exploration at its Mexican Hat gold property, hosting 688,000 oz gold resource. See expansion plans inside.

Mesoblast seeks FDA accelerated approval for Revascor in ischemic heart failure. Key meeting to discuss manufacturing and confirmatory trial design. Full analysis inside.

77% of ISG Australia employees rate it as a great workplace, with 8% YoY improvement. Strong culture metrics revealed in 88% staff participation survey.

Trading houses offer up to $6M in competitive offtake financing for Peru silver mine restart. Flexible terms include grace periods. Deal closing targeted for April.

Eguana reduces 451M shares to 45M through strategic 10:1 consolidation. New trading structure effective April 4, 2025. See full impact analysis.